CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-23 | Naydenov Jordan G Director | Option exercise | +888,888 | $0.45 | $400K | 7,590,211 |
| 2021-09-23 | Naydenov Jordan G Director | Option exercise | +133,332 | $0.75 | $100K | 7,723,543 |
| 2021-09-23 | Naydenov Jordan G Director | Option exercise | +266,668 | $0.75 | $200K | 7,990,211 |
| 2021-09-23 | Naydenov Jordan G Director | Returned to the company · Warrant (Right to Buy) | −444,444 | 0 | ||
| 2021-09-23 | Naydenov Jordan G Director | Returned to the company · Warrant (Right to Buy) | −66,666 | 0 | ||
| 2021-09-23 | Naydenov Jordan G Director | Returned to the company · Warrant (Right to Buy) | −133,334 | 0 | ||
| 2021-09-23 | Naydenov Jordan G Director | Grant or award · Warrant (Right to Buy) | +888,888 | 888,888 | ||
| 2021-09-23 | Naydenov Jordan G Director | Grant or award · Warrant (Right to Buy) | +133,332 | 133,332 | ||
| 2021-09-23 | Naydenov Jordan G Director | Grant or award · Warrant (Right to Buy) | +266,668 | 266,668 | ||
| 2021-09-23 | Naydenov Jordan G Director | Option exercise · Warrant (Right to Buy) | −888,888 | 0 | ||
| 2021-09-23 | Naydenov Jordan G Director | Option exercise · Warrant (Right to Buy) | −133,332 | 0 | ||
| 2021-09-23 | Naydenov Jordan G Director | Option exercise · Warrant (Right to Buy) | −266,668 | 0 | ||
| 2021-08-06 | Pourhassan Nader President & CEO | Grant or award | +75,758 | 1,650,688 | ||
| 2021-08-06 | Pourhassan Nader President & CEO | Grant or award | +200,000 | 1,850,688 | ||
| 2021-08-06 | Kelly Scott A. Chairman & CMO | Grant or award | +40,661 | 1,781,713 | ||
| 2021-08-06 | Kelly Scott A. Chairman & CMO | Grant or award | +153,350 | 1,935,063 | ||
| 2021-08-06 | Ray Nitya G. Chief Technology Officer | Grant or award | +34,801 | 234,801 | ||
| 2021-08-06 | Ray Nitya G. Chief Technology Officer | Grant or award | +52,500 | 287,301 | ||
| 2021-08-06 | Ray Nitya G. Chief Technology Officer | Grant or award · Non-qualified stock option (right to buy) | +500,000 | 500,000 | ||
| 2021-08-06 | Migliarese Antonio Chief Financial Officer | Grant or award | +3,023 | 3,023 |
Page 8 of 33 · 652 trades